Skip to main content
logo
Biocon Limited (BOM:532523)
India flag India · Delayed Price · Currency is INR
425.65
+0.10 (0.02%)
At close: Jul 31, 2026

Biocon Cash Flow Statement

Millions INR. Fiscal year is Apr - Mar.

Operating Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Net Income
3,85610,13310,2254,6276,484
Depreciation & Amortization
19,04416,40315,34111,1318,142
Other Amortization
523467347--
Loss (Gain) From Sale of Assets
158-10,497125223
Asset Writedown & Restructuring Costs
-863,945470-
Loss (Gain) From Sale of Investments
-1,632415-7,008-1,978-146
Loss (Gain) on Equity Investments
--8421,6702,069
Stock-Based Compensation
1,6391,3701,0061,3761,257
Provision & Write-off of Bad Debts
529290-17164248
Other Operating Activities
7,14512,71511,3526,1231,584
Change in Accounts Receivable
6,2445,482-24,17415,905-4,736
Change in Inventory
-9,178-3-8,8648,862-4,140
Change in Accounts Payable
-1,9175,80829,365-37,3591,618
Change in Other Net Operating Assets
-6,471-2,057-2,6797,582-637
Operating Cash Flow
19,94040,61229,53918,52511,766
Operating Cash Flow Growth
-50.90%37.49%59.46%57.45%1.46%

Investing Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Capital Expenditures
-17,979-21,366-16,805-15,960-16,978
Sale of Property, Plant & Equipment
-32333121
Cash Acquisitions
---5,532-156,645-
Divestitures
-18,252-34,474-
Sale (Purchase) of Intangibles
-1,138-2,067-2,511-1,303-2,270
Investment in Securities
-3,1841,66513,124-4,6482,314
Other Investing Activities
1,4801,1721,4461,233-78
Investing Cash Flow
-20,821-2,341-10,045-142,818-16,991

Financing Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Short-Term Debt Issued
3496,8461,24815,0413,461
Long-Term Debt Issued
2,66496,58213,718109,39910,701
Total Debt Issued
3,013103,42814,966124,44014,162
Long-Term Debt Repaid
-49,703-99,087-28,096-395-11,070
Total Debt Repaid
-49,703-99,087-28,096-395-11,070
Net Debt Issued (Repaid)
-46,6904,341-13,130124,0453,092
Issuance of Common Stock
86,01599307295428
Repurchase of Common Stock
-26---647-3
Common Dividends Paid
-669-600-2,030-599-
Other Financing Activities
-47,866-22,380-8,4747,393-1,096
Financing Cash Flow
-9,236-18,540-23,327130,4872,421

Net Cash Flow

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Foreign Exchange Rate Adjustments
1,9943122921733
Miscellaneous Cash Flow Adjustments
----338
Net Cash Flow
-8,12320,043-3,8046,411-2,433

Free Cash Flow

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Free Cash Flow
1,96119,24612,7342,565-5,212
Free Cash Flow Growth
-89.81%51.14%396.45%--
Free Cash Flow Margin
1.16%12.61%8.63%2.30%-6.37%
Free Cash Flow Per Share
1.4316.0610.642.15-4.36
Levered Free Cash Flow
913.38-28,16227,6131,402-12,380
Unlevered Free Cash Flow
6,943-22,61433,7034,021-11,958

Additional Metrics

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash Interest Paid
8,6546,3428,4744,8561,096
Cash Income Tax Paid
2,4264,5962,9232,2862,620
Change in Working Capital
-11,3229,230-6,352-5,010-7,895